Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 2–2 | Cite as

Increased risk of mortality with paclitaxel-containing devices?

News item
  • 16 Downloads

References

  1. 1.
    Health Products Regulatory Authority. Paclitaxel-coated balloons and Paclitaxel-eluting stents used for peripheral artery disease. Internet Document : [3 pages], 2 May 2019. Available from: URL: https://www.hpra.ie/docs/default-source/Safety-Notices/sn201913_variousmfrs_paclitaxel_v38414.pdf?sfvrsn=2
  2. 2.
    Government of Canada. Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality. Internet Document : 6 May 2019. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69848a-eng.php#fn1

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations